Hypercortisolism: Causes, Consequences and Clinical Significance – A Review of Pathophysiology
Diabetes, Obesity and Metabolism · 2026
DOI: 10.1111/dom.71022 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Diabetes, Obesity and Metabolism, 2026. Verfasst von Mohamed Eldib und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, Diabetes and Metabolism, Cleveland Clinic, Cleveland, Ohio, USA. Hauptthemen laut MEDLINE: Cushing Syndrome. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 120 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Hypercortisolism or Cushing syndrome is a heterogeneous clinical spectrum caused by chronic glucocorticoid excess, ranging from exogenous Cushing syndrome to rare endogenous aetiologies and the increasingly recognised entity of mild autonomous cortisol secretion (MACS). Physiological cortisol production is tightly regulated by the hypothalamic–pituitary–adrenal axis, and disruption at any level may lead to clinically significant cortisol excess. Endogenous hypercortisolism is broadly classified into corticotropin‐dependent and corticotropin‐independent forms. The clinical phenotype varies according to the source, severity, and duration of cortisol excess. Overt Cushing syndrome is classically associated with centripetal adiposity, proximal myopathy, skin fragility, hypertension, and glucose intolerance, whereas MACS lacks overt cushingoid features despite conferring substantial cardiometabolic and skeletal risk. Cortisol excess affects multiple organ systems, including endocrine, cardiovascular, hepatic, musculoskeletal, neuropsychiatric, immune, dermatologic, and reproductive pathways. Importantly, many complications persist despite biochemical remission, underscoring the long‐term burden of disease. This review summarises the aetiologies, pathophysiology, clinical manifestations, and systemic consequences of hypercortisolism.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Endocrinology, Diabetes and Metabolism, Cleveland Clinic, Cleveland, Ohio, USA.
- Escuela de Medicina, Universidad San Francisco de Quito, Quito, Ecuador.
ORCID-Profile: Mohamed Eldib, Francisco Emilio Fierro
Zitieren
APA
Eldib, M., Fierro, F. E., Abad, M. O., & Correa, R. (2026). Hypercortisolism: Causes, Consequences and Clinical Significance – A Review of Pathophysiology. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/dom.71022
Vancouver
Eldib M, Fierro FE, Abad MO, Correa R. Hypercortisolism: Causes, Consequences and Clinical Significance – A Review of Pathophysiology. Diabetes, Obesity and Metabolism. 2026. doi:10.1111/dom.71022
BibTeX
@article{Eldib2026,
author = {Eldib, Mohamed and Fierro, Francisco Emilio and Abad, Maria Ortega and Correa, Ricardo},
title = {Hypercortisolism: Causes, Consequences and Clinical Significance – A Review of Pathophysiology},
journal = {Diabetes, Obesity and Metabolism},
year = {2026},
doi = {10.1111/dom.71022}
}
EUVIMED